Science Explorer Back to mapMap
Discussion
Researcher · Champalimaud Foundation · Portugal

Paulo Lúcio

Paulo Lúcio publishes mostly in Hematology, Molecular Biology and Genetics, on topics such as Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research and Protein Degradation and Inhibitors.

ORCID 0000-0003-0175-7534 OpenAlex
World rank
#1,270,521
of 7,710,434 ranked researchers
Rank in Portugal
#5,087
of 41,760
Works
72
Citations
4.5k
Citations per work
62.5
h-index
24
i10-index 36Top 18% in Hematology
Paulo Lúcio

What does Paulo Lúcio research?

Paulo Lúcio's work is mostly in Medicine (57%), Biochemistry, Genetics and Molecular Biology (19%).

Health Sciences: 41 works · 57.3% of their workMedicine: 41 works · 57.3% of their workHematology: 20 works · 28.4% of their workGenetics: 7 works · 9.8% of their workOncology: 6 works · 8.8% of their workPathology and Forensic Medicine: 4 works · 5.7% of their workPublic Health, Environmental and Occupational Health: 3 works · 4.6% of their workEverything else: 17 works · 24.1% of their workLife Sciences: 13 works · 18.6% of their workBiochemistry, Genetics and Molecular Biology: 13 works · 18.6% of their workMolecular Biology: 13 works · 18.6% of their workTHEIR WORKPaulo Lúcio72works
Life Sciences19%Health Sciences57%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4157.3%
  2. Everything else1724.1%
    1. Biochemistry, Genetics and Molecular Biology1318.6%
  1. 1Hematology28% of their works
  2. 2Molecular Biology19% of their works
  3. 3Genetics10% of their works
  4. 4Oncology9% of their works
  5. 5Pathology and Forensic Medicine6% of their works
  6. 6Public Health, Environmental and Occupational Health5% of their works

Research topics

Which keywords describe Paulo Lúcio's research?

The keywords of their largest research topics: Minimal Residual Disease, Diagnosis Criteria, International Myeloma Working Group, Prognostic Factors, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations and BET Bromodomains.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Minimal Residual Disease422 topics
  2. Diagnosis Criteria341 topic
  3. International Myeloma Working Group341 topic
  4. Prognostic Factors313 topics
  5. Rituximab242 topics
  6. Chronic Lymphocytic Leukemia151 topic
  7. Genomic Aberrations151 topic
  8. BET Bromodomains101 topic
  9. PROTACs101 topic
  10. BCR-ABL91 topic
  11. Classification91 topic
  12. Imatinib91 topic
  13. Lymphoma91 topic
  14. AML81 topic
  15. Acute Lymphoblastic Leukemia81 topic
  16. Acute Myeloid Leukemia81 topic
  17. Childhood Cancer81 topic
  18. Signaling71 topic
  19. mTOR71 topic

Where does Paulo Lúcio work?

Paulo Lúcio's main affiliation in the publication record is Champalimaud Foundation, Portugal.

How many publications and citations does Paulo Lúcio have?

OpenAlex counts 72 works and 4,502 citations for Paulo Lúcio, an h-index of 24, ranking #1,270,521 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Paulo Lúcio. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.